Lv11
40 积分 2025-05-21 加入
Investigating the shared genetic architecture between schizophrenia and body mass index
1小时前
已完结
Effects of 1-year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes
2个月前
已完结
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
3个月前
已完结
Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial
4个月前
已完结
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
4个月前
已完结
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
4个月前
已完结
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
6个月前
已完结
Temporal Trends for Diabetes Management and Glycemic Control Between 2010 and 2019 in Korean Children and Adolescents with Type 1 Diabetes
6个月前
已完结
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
6个月前
已完结
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
6个月前
已完结
皖公网安备34019202002308
